Rohit Mehtani
@RohitMehtaniDM
Followers
2K
Following
7K
Media
226
Statuses
3K
Hepatologist @amritafbd | Trained @HepatologyPGI | Passionate for clinical research | 🚫#Pseudoscience | Liver ❤️| #LiverTwitter
Faridabad, India
Joined December 2012
Glad to inform that I have joined as Assistant Professor in the Department of #Hepatology @amritafbd Amrita Hospitals, Faridabad, India. Looking forward to be a part of a centre of excellence for liver diseases and transplantation! #LiverTwitter #GITwitter
@HepatologyPGI
27
3
119
🚀 Calling Hepatology Researchers 🌏 Submit your 📃 to JCEH – the flagship journal of INASL 🇮🇳 📊 ⭐ Impact Factor: 3.2 ⏱️ 5 days to first decision ⚡ 5 days from acceptance to online publication 🔬 Rapid review. Global reach. High visibility 📢 Submit now
0
2
4
New @JCEH_Hepatology Prolonged cholestasis after AVH is rare but tough! This study shows that Plasma Exchange + low-dose steroids 📈 up bilirubin fall & symptom relief compared to SOC. ⚡️💊 👉 Rescue option @drsuniltaneja @ajay_duseja @RohitMehtaniDM
https://t.co/sKyeS4GGJr
jcehepatology.com
Prolonged cholestasis after acute viral hepatitis (AVH) complicates <1% of patients. The treatment includes the use of anti-pruritic medications in a stepwise manner. This study assessed the role of...
0
4
9
It was wonderful hosting you sir @amritafbd .. hoping to see you again soon!
Learning-filled & truly humbling experience 🙏 It was a privilege to be associated with @CAMO_Net1 and to present at @amritafbd, contributing in a small way to the fight against the rising epidemic of AMR 🧫🦠 Grateful for the opportunity and inspired to do more. 💪✨
0
1
5
Don't do a Fibroscan and go see a doctor. Go see a doctor and see if you need a Fibroscan.
24
39
654
@HepatologyPGI also won the Gold at the @ICMRDELHI Research Excellence Awards for our paper on Recompensation in HCV cirrhosis. - Gastroenterology https://t.co/QkKlvQlOAN
@ajay_duseja @RadhaKDhiman @drnipunverma @drsuniltaneja @doc_arka @JCEH_Hepatology @RoyAHep @RohitMehtaniDM
gastrojournal.org
In a public health model in resource-constrained regions, treatment of hepatitis C virus with generic, free-of-cost, directly acting antiviral agents in patients with decompensated cirrhosis leads to...
5
4
38
Grand start to the @IJG_Journal Editorial Fellowship Meeting. Insights and Tips from GI Greats @JCEH_Hepatology @RoyAHep @AnandVKulkarni2 @drvishal82 @RohitMehtaniDM @drsridhars @stevenbollipo @giri_gutnliver #livertwitter
1
9
23
Learn from the Greats @drsridhars @IJG_Journal @JCEH_Hepatology @RoyAHep @AnandVKulkarni2 @drvishal82 @RohitMehtaniDM IJG editorial fellowship 2025
2
6
14
As an academic gastroenterologist who enjoys doing clinical research, I still love this meme. Stay grounded folks. #GITwitter
0
4
62
Many patients and even relatives often say that doctors from earlier generations were better, that they did not need so many tests and could just look at the patient and write medicines. I always smile when I hear this because medicine has never been about guessing, it has
50
148
692
#ASEPTIC=final nail in⚰️#SBPproph in #cirrhosis..but the fight vs #AMR is brewing for a while. https://t.co/5NdPDxMxTO
https://t.co/XgjkLdQSZd
https://t.co/gSBm6sfDLv
https://t.co/aFp4UlqUzX
https://t.co/b4vHkfkcGw
@ABsteward @PaulSaxMD Times are changing & ID/hep are together!
1
13
51
0
0
0
All good things come to an end.. Washington DC you have been kind!! Wonderful time learning all things #liver @AASLDtweets #TLM2025 &connecting with friends and colleagues across the globe! Looking forward to #TLM2026!! #Livertwitter
2
2
23
Its a wrap @AASLDtweets #TLM2025 It was loads of fun meeting old friends, and making new connections, and updating knowledge on all things liver… Looking forward to next year! #LiverTwitter
0
3
25
Palliative care in Cirrhosis !! Such an important topic, clearly and thoughtfully addressed by Fasiha Kanwal. @RoyAHep @RohitMehtaniDM @ajay_duseja @AASLDtweets
0
6
14
0
0
5
Heading to Washington DC for @AASLDtweets #TLM2025 ! A great opportunity to connect with peers, exchange ideas, and advance liver disease research! See you in DC Nov 7-11! #Livertwitter
@RoyAHep @ajay_duseja @drsuniltaneja @AnandVKulkarni2 @ebtapper @DrArunKValsan @drbabupgi
2
2
16
RIP FFP Devastating study for FFP: does not normalize coagulation function and often makes it worse #cirrhosis Link: https://t.co/cJcezio9hC
22
172
425
Useful tips for all those travelling to Washington DC for @AASLDtweets The Liver Meeting! #livertwitter
@INASL_Liver @RoyAHep @DrArunKValsan
@drsuniltaneja @ajay_duseja @docMPK @drnipunverma @AnandVKulkarni2 @drbabupgi
How to pack for a professional conference All this using only 1 carry-on + 1 personal item, no checked luggage 🙂 Work with @TrudyWuMD
2
1
9
If systemic hypotension was the sole cause of ischemic hepatitis, every patient in the MICU would have ALT >500 But the incidence is 1 in 50 You need right heart failure, congestion, that exceeds portal pressure. Then the systemic bp drop can be transient or relative
Being a hepatologist means you diagnose a LOT of heart failure 1. Ascites, often with high total protein 2. ALT > 400 is most often due to ischemic hepatitis. This is caused most by venous congestion and less by systemic hypotension. echo often unhelpful
5
40
256